» Articles » PMID: 15180520

Proteasome Function in Antigen Presentation: Immunoproteasome Complexes, Peptide Production, and Interactions with Viral Proteins

Overview
Specialty Biochemistry
Date 2004 Jun 8
PMID 15180520
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Proteasomes are the major nonlysosomal protein degradation machinery in eukaryotic cells and they are largely responsible for the processing of antigens for presentation by the MHC class I pathway. This review concentrates on recent developments in the area of antigen processing. Specialized proteasomes called immunoproteasomes and an 11S regulator of proteasomes (PA28) are induced by interferon-gamma, but it is not entirely clear why changes in proteasome structure are beneficial for antigen presentation. Different proteasome complexes have distinct subcellular distributions and subtle differences in cleavage specificity. Thus it is likely that the efficiency of production of MHC class I binding peptides varies in different locations. Immunoproteasome subunits are enriched at the ER where TAP transports peptides for association with newly synthesized MHC class I molecules. There is recent evidence to suggest that antigen presentation from viral expression vectors, or from peptides that are either delivered by bacterial toxins or derived from signal peptides, require proteasome activity for generation of the correct C-terminus of the epitope. The correct N-terminus may be generated by recently identified ER associated aminopeptidases. A number of viral protein interactions with proteasome subunits have been reported and such interactions may interfere with host anti-viral defenses and also contribute to mechanisms of cell transformation.

Citing Articles

Obesity-Associated Changes in Immune Cell Dynamics During Alphavirus Infection Revealed by Single Cell Transcriptomic Analysis.

Hameed M, Daamen A, Hossain M, Coutermarsh-Ott S, Lipsky P, Weger-Lucarelli J bioRxiv. 2024; .

PMID: 39416014 PMC: 11482886. DOI: 10.1101/2024.10.10.617696.


Targeting Proteasomes and the MHC Class I Antigen Presentation Machinery to Treat Cancer, Infections and Age-Related Diseases.

Rana P, Ignatz-Hoover J, Driscoll J Cancers (Basel). 2023; 15(23).

PMID: 38067336 PMC: 10705104. DOI: 10.3390/cancers15235632.


Isolation of Proteasome-Trapped Peptides (PTPs) for Degradome Analysis.

Sahu I, Sahoo M, Kleifeld O, Glickman M Methods Mol Biol. 2022; 2602:229-241.

PMID: 36446979 DOI: 10.1007/978-1-0716-2859-1_17.


PSMB5 overexpression is correlated with tumor proliferation and poor prognosis in hepatocellular carcinoma.

Liu J, Mi J, Liu S, Chen H, Jiang L FEBS Open Bio. 2022; 12(11):2025-2041.

PMID: 36062301 PMC: 9623531. DOI: 10.1002/2211-5463.13479.


Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML.

Zhang Y, Xue S, Hao Q, Liu F, Huang W, Wang J J Cancer. 2021; 12(14):4257-4263.

PMID: 34093826 PMC: 8176406. DOI: 10.7150/jca.53686.